Know Cancer

or
forgot password


N/A
19 Years
N/A
Not Enrolling
Both
Pancreatic Neoplasm

Thank you

Trial Information


Inclusion Criteria:



-All patients with solid pancreatic mass lesions

Exclusion Criteria:

- Coaguloapthy,

- minors,

- prgenant patients

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Compare the median number of passes required to establish a diagnosis

Outcome Time Frame:

6 months

Safety Issue:

No

Principal Investigator

Shyam Varadarajulu, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alabama at Birmingham

Authority:

United States: Institutional Review Board

Study ID:

F110506010

NCT ID:

NCT01394159

Start Date:

July 2011

Completion Date:

December 2011

Related Keywords:

  • Pancreatic Neoplasm
  • passes required to establish diagnosis
  • Neoplasms
  • Pancreatic Neoplasms

Name

Location

University of Alabama at BirminghamBirmingham, Alabama  35294-3300